US Broker Ratings

Intellia Therapeutics, Inc. (NTLA): Analyst Ratings Signal 95% Upside Potential for Genome Editing Pioneer

Intellia Therapeutics, Inc. (NASDAQ: NTLA) stands at the forefront of the biotechnology industry with its pioneering efforts in genome editing. As a clinical-stage company specializing in..

Nutex Health Inc. (NUTX): Investor Outlook Reveals a Promising 70.89% Potential Upside

Nutex Health Inc. (NUTX) is garnering attention from investors with a compelling potential upside of 70.89%, highlighted by its average target price of $230.00. As a..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: A Biotech Contender with a 164% Potential Upside

Gyre Therapeutics, Inc. (GYRE), a notable player in the biotechnology sector, presents a compelling opportunity for investors seeking exposure in the healthcare industry. Headquartered in San..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 10.60% Potential Upside

Bausch + Lomb Corporation (NYSE: BLCO), a venerable name in eye health solutions, is capturing the attention of investors with a notable potential upside of 10.60%...

Krystal Biotech, Inc. (KRYS) Investor Outlook: Exploring a Promising 18.40% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is capturing the attention of investors with its robust market cap of $7.83 billion and a promising pipeline of genetic medicines..

Elanco Animal Health (ELAN) Stock Analysis: Impressive Revenue Growth and Strong Buy Ratings Propel Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN), with its $11.24 billion market cap, presents an intriguing opportunity for investors within the healthcare sector, particularly in the niche..

TransMedics Group, Inc. (TMDX) Investor Outlook: A Healthcare Innovator with a 55.98% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX), a rising star in the healthcare sector, is drawing investor attention with its innovative approach to organ transplantation and an impressive..

Grifols, S.A. (GRFS) Valuation Insights: Unlocking a 34.87% Potential Upside in Healthcare Innovation

Grifols, S.A. (NASDAQ: GRFS), a Spanish healthcare giant specializing in plasma-derived medicines, stands at an intriguing crossroads for investors, especially as the stock currently trades at..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Exploring a 47.3% Potential Upside in Biotech Innovation

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, commands investor attention with a robust market capitalization of $7.87 billion. The company stands at..

Bruker Corporation (BRKR) Investor Outlook: Exploring a 27% Potential Upside in the Healthcare Sector

Bruker Corporation (NASDAQ: BRKR), a prominent name in the healthcare sector, specializes in the development, manufacturing, and distribution of scientific instruments, as well as analytical and..

Exelixis, Inc. (EXEL) Investor Outlook: Exploring a Promising 8.81% Upside Potential

Exelixis, Inc. (EXEL), a prominent player in the biotechnology sector, has captured investor attention with its focus on groundbreaking oncology therapies. Specializing in the discovery and..

Integer Holdings Corporation (ITGR): Analyst Consensus Highlights a 13% Potential Upside

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector specializing in medical devices, has drawn significant attention from investors with its solid growth..

Regencell Bioscience Holdings L (RGC): Growth Potential in the Booming TCM Market

Investors intrigued by the burgeoning Traditional Chinese Medicine (TCM) sector should keep an eye on Regencell Bioscience Holdings L (NASDAQ: RGC), a promising player in the..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 43.75% Potential Upside with Promising Oncology Innovations

Nuvalent, Inc. (NASDAQ: NUVL), a burgeoning player in the biotechnology sector, has captured the attention of investors with a market capitalization of $7.82 billion. Specializing in..

Sarepta Therapeutics (SRPT) Stock Analysis: Navigating the Biotech Terrain with a 1.36% Potential Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, offers a compelling yet complex investment narrative for those interested in the healthcare industry...

The Cooper Companies, Inc. (COO) Stock Analysis: A Look at Its 46% Potential Upside

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, presents a compelling opportunity for..

BrightSpring Health Services (BTSG) Stock Analysis: Strong Buy Ratings and 7.73% Potential Upside

BrightSpring Health Services, Inc. (BTSG) is making waves in the healthcare sector, specifically within the health information services industry. As a prominent player in delivering comprehensive..

Humana Inc. (HUM) Stock Analysis: Navigating Healthcare Growth with a 2.94% Upside Potential

Humana Inc. (NYSE: HUM), a prominent player in the healthcare plans industry, is capturing investor attention with its robust revenue growth and a strategic focus on..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a Promising 42% Upside Potential

Prestige Consumer Healthcare Inc. (PBH) stands out in the healthcare sector with a robust portfolio of over-the-counter (OTC) health and personal care products. Based in Tarrytown,..

Doximity, Inc. (DOCS) Stock Analysis: Analyst Ratings Suggest 51% Potential Upside in Healthcare Tech

Doximity, Inc. (NYSE: DOCS), a prominent player in the healthcare technology sector, is capturing the attention of individual investors with an impressive potential upside of 51.21%,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds